The Effect of Nutrition Education Given by Pecha Kucha Method on Preventing Malnutrition to Cancer Patients Receiving Radiotherapy

The leading goal of cancer treatment is to eradicate the cancer. If the primary goal is not achieved, it is aimed to prolong life, improve quality of life, or improve symptoms. Cancer treatments are divided into two basic groups as local and systemic. Systemic treatments include chemotherapy, hormone therapy, targeted molecular therapy, immunotherapy treatments. Local treatments are; ablative approaches that include surgery, cryotherapy, radiotherapy and radiofrequency. Radiotherapy (RT) is a treatment method in which ionizing beam is used. The aim of radiotherapy in cancer treatment is to destroy the tumor, if this is not possible, to provide palliative treatment. Radiotherapy uses ionizing radiation in the form of electromagnetic waves (x-rays, gamma rays) or particles for this purpose. Pecha Kucha (PK), meaning "chat voice" or "chat" in Japanese, refers to a well-crafted, fast and concise presentation format. In a PK presentation, each presenter is only allowed to show 20 PowerPoint slides for 20 seconds each on a timer. In other words, the presenter has only 20 seconds to discuss each slide before the next slide appears, and the presentation time is limited to 6 minutes and 40 seconds. Ideas are explained visually with pictures and graphics, and slides have little text.

Study Overview

• Status: Completed
• Conditions: Preventing Malnutrition
• Intervention / Treatment: Behavioral: pecha kucha

Detailed Description

According to the report of the World Health Organization, the increase in cancer is predicted to be over 70% by 2020 in developing countries.

While a significant increase in the life span of cancer patients has been achieved with effective multi-faceted treatment approaches in recent years, nutritional problems related to cancer and cancer treatment have begun to emerge as an important factor in quality of life and survival. Early detection of nutritional disorders and initiation of necessary nutritional support are of great importance in increasing the effect of radiotherapy and chemotherapy, reducing infection rates, increasing clinical response and life expectancy. Pecha Kucha (PK), meaning "chat voice" or "chat" in Japanese, refers to a well-crafted, fast and concise presentation format. In a PK presentation, each presenter is only allowed to show 20 PowerPoint slides for 20 seconds each on a timer. In other words, the presenter has only 20 seconds to discuss each slide before the next slide appears, and the presentation time is limited to 6 minutes and 40 seconds. Ideas are explained visually with pictures and graphics, and slides have little text.

• Study Type: Interventional
• Enrollment (Actual): 60
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Merkez
    • Elazığ, Merkez, Turkey, 23000
      • Gülcan B.Turan

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• • Patients over 18 years of age

  • Patients receiving radiotherapy for the first time
  • Patients with cachectic and diagnosed mental problems
  • Patients who can read and write or who can get support from their relatives
  • Patients who can be contacted

Exclusion Criteria:

-

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Sequential Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: control; Routine maintenance will be applied.
Experimental: Experimental: pecha kucha will be practiced	Behavioral: pecha kucha; pecha kucha training

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
NRS-2002 (Nutritional Risk Screening) Evaluation Form	The development of scale was done with a different method compared to the development of other scanning tools. The scoring system consists of two parts as 'nutritional status' and 'disease severity' and provides scoring as 'no problem', 'mild', 'moderate' and 'severe'. Scoring is made between 0-3 for each section. In addition to scoring in patients over the age of seventy, 1 more point is added to the score due to age. Patients with a total score of ≥3 are considered to be at nutritional risk.	1 hours later
Subjective Global Assessment (SGD)	The Subjectif Global Assessment scale (SGD) is a clinical technique that is described based on anamnesis and physical examination characteristics. The major components of SGD are weight loss in the last 6 months and weight loss in the last 2 weeks. In the physical examination, it is questioned whether there is loss of subcutaneous adipose tissue, muscle wasting, ankle/scrotal edema and ascites. The history is taken from the patient, if possible, or from a family member if not. It is very important to consider the primary disease and the nutritional requirements associated with the disease. The clinician should be unaware of the patient's laboratory findings in terms of the subjective nature of the method in SGD. After recording the parameters related to the subjective global assessment, the patient is evaluated in three categories: 'well-nourished' (A), 'moderately or suspected malnourished' (B) and 'severely malnourished' (C).	1 hours later

Collaborators and Investigators

• Sponsor: Ataturk University

Study record dates

Study Major Dates

• Study Start (Actual): March 1, 2023
• Primary Completion (Actual): April 1, 2023
• Study Completion (Actual): July 30, 2023

Study Registration Dates

• First Submitted: May 1, 2023
• First Submitted That Met QC Criteria: May 1, 2023
• First Posted (Actual): May 10, 2023

Study Record Updates

• Last Update Posted (Actual): May 7, 2025
• Last Update Submitted That Met QC Criteria: May 5, 2025
• Last Verified: May 1, 2025

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Nutrition Disorders; Malnutrition
• Other Study ID Numbers: 2023/ 03- 23

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No